Texas executes man as lawyers cite failed Tennessee lethal injection

Jamaal Howard was executed by lethal injection on Wednesday evening in Texas, becoming the thirtieth person put to death in the United States this year and the first since Tennessee's failed attempt to execute Christa Pike using the same drug. Howard, forty-six, was pronounced dead at 8:03 p.m. local time after receiving a fatal dose of pentobarbital at the state prison in Huntsville. He had been convicted of killing Vickie Swartout, a forty-two-year-old convenience store clerk, during a robbery in the year 2000 in Silsbee, a small rural town about a hundred miles northeast of Houston. Surveillance video from the store captured the shooting. Howard, who was twenty at the time, took $114 and a carton of cigarettes before leaving.

In his final moments, Howard apologized to members of Swartout's family who watched through a window positioned a few feet from where he lay. The Texas Department of Criminal Justice described him as talkative throughout the process—chatty during the forty-five-mile drive from death row to the execution facility, asking questions and making small talk with officers, remaining engaged even as he was moved to the holding cell near the death chamber.

His attorneys had mounted a last-minute legal challenge, filing motions to block the execution on two separate grounds. They argued that Howard was intellectually disabled and therefore ineligible for execution under a 2002 Supreme Court ruling that barred capital punishment for people with intellectual disabilities. They also raised concerns about the lethal injection drug itself. The lawyers pointed to Pike's case in Tennessee, where the fifty-year-old survived two doses of pentobarbital on September 30th. Pike was hospitalized following the failed execution, and her attorneys alleged the procedure was marred by blown veins—where a needle pierces completely through a vein, causing blood and fluid to leak into surrounding tissue—as well as deteriorated pentobarbital and inadequate emergency medical care.

Howard's legal team argued that Texas faced similar risks. They contended that the state's execution drugs were likely degraded, having been stored far beyond the expiration dates established by the pharmacopeia for such medications. They also raised questions about whether Texas would disclose information about the specific pentobarbital batch being used, noting that the state had requested an attorney general opinion on disclosure requirements despite a years-long practice of providing such information. "Texas should not be eager to follow in Tennessee's footsteps; a stay would keep that from happening," the attorneys wrote in their filing.

The Texas Court of Criminal Appeals denied the request for a stay without elaboration. When Howard's team filed a second motion challenging the execution drug itself, that too was denied without comment. The U.S. Supreme Court declined a late appeal Wednesday evening, also without explanation.

The state maintained that Howard had not presented sufficient evidence to meet the legal threshold for an intellectual disability claim. Texas officials did not immediately respond to requests for comment about the drug disclosure questions.

Howard's execution marked the sixth carried out in Texas this year, with two more scheduled to follow. Nationally, Florida has led all states with sixteen executions in 2026. The case underscores an emerging tension in capital punishment: as states continue to rely on lethal injection as their primary execution method, questions about drug quality, medical protocols, and the potential for procedural failure are becoming harder to ignore. Tennessee's governor has called for a moratorium on executions for the remainder of the year following Pike's case, but other states have shown no signs of pausing their schedules.